GE Healthcare AI Models Predict Immunotherapy Response with 70-80% Accuracy Using Routine Patient Data

New data shows GE HealthCare's AI models predict patient response to immunotherapies with 70-80% accuracy.

Models use routine EHR data, enabling potential broad application to guide precision, personalized care.

After regulatory approvals, models to be commercialized for pharmaceutical and clinical use.

Developed on data from >7,000 patients at Vanderbilt and University Medicine Essen.

Part of GE Healthcare's immuno-oncology portfolio; first-of-kind CD8 PET tracer in clinical trials.